Larynx preservation with primary non-surgical treatment for loco-regionally advanced larynx cancer

Journal of Medical Imaging and Radiation Oncology

Volumn 55, Issue 2, 2011, Pages 229-235

  Corry, June ^a,b,h   Rischin, Danny ^b,h   Cotton, Sue ^c   D'Costa, Ieta ^a   Chua, Margaret ^a   Vallance, Neil ^d   Lyons, Bernard ^e   Kleid, Stephen ^f   Sizeland, Andrew ^g   Peters, Lester J ^a,h  

^a Radiation Oncology   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^d MONASH MEDICAL CENTRE   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

^g Western Hospital   (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

altered fractionation; chemotherapy; larynx cancer; larynx preservation; radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; TIRAPAZAMINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; DISEASE CONTROL; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HYPOTHYROIDISM; LARYNGECTOMY; LARYNX CANCER; LARYNX PRESERVATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; ORGAN PRESERVATION; OVERALL SURVIVAL; PRIORITY JOURNAL; TINNITUS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79955065663     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2011.02256.x     Document Type: Article

References (24)

1. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiotherapy compared with surgery in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-90.
2. Wolf GT, Hong WK, Gross Fisher S, et al,. Re-examining the treatment of advanced laryngeal cancer: the VA laryngeal cancer study revisited. Head Neck 2010; 32: 7-14.
3. Brizel DM, Albers ME, Fisher SR, et al,. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338: 1798-804. (Pubitemid 28277960)
4. Calais G, Alfonsi M, Bardet E, et al,. Randomized trial of RT versus concomitant chemotherapy and radiation therapy for advanced stage oropharyngeal cancer. J Natl Cancer Inst 1999; 91: 2081-6. (Pubitemid 30019568)
5. Wendt TG, Grabenbauer GG, Rodel CM, et al,. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicentre trial. J Clin Oncol 1998; 16: 1318-24. (Pubitemid 28175746)
6. Adelstein DJ, Lavertu P, Saxton JP, et al,. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000; 88: 876-83. (Pubitemid 30091108)
7. Pignon JP, Bourhis J, Domenge C, Designe L,. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 2000; 355: 949-55. (Pubitemid 30148259)
8. Mendenhall WM, Parsons JT, Mancuso AA, et al,. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery. Head Neck 1996; 18: 24-35. (Pubitemid 26002034)
9. Mendenhall WM, Parsons JT, Mancuso AA, et al,. Definitive radiotherapy for T3 squamous cell carcinoma of the glottic larynx. J Clin Oncol 1997; 15: 2394-402. (Pubitemid 27251143)
10. Parson JT, Mendenhall WM, Stringer SP, et al,. T4 laryngeal carcinoma: radiotherapy alone with surgery reserved for salvage. Int J Radiat Oncol Biol Phys 1998; 40: 549-52. (Pubitemid 28104223)
11. Haugen H, Johansson KA, Hasse E, Edstrom S, Mercke C,. Accelerated radiotherapy for advanced laryngeal cancer. Acta Oncol 2005; 44: 481-9. (Pubitemid 41191781)
12. Hinerman RW, Mendenhall WM, Morris MS, Amdur AJ, Werning JW, Villaret DB,. T3 and T4 true vocal cord squamous carcinomas treated with external beam irradiation. Am J Clin Oncol 2007; 30: 181-5.
13. Forastiere AA, Goepfert H, Maor M, et al,. Concurrent chemotherapy radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-8. (Pubitemid 37464533)
14. Forastiere AA, Maor M, Wever RS, et al,. Long-term results of Intergroup RTOG 91-11: A phase III trial to preserve the larynx-Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. J Clin Oncol 2006; 24 (Suppl 18): 5517.
15. Corry J, Rischin D, Peters LJ, et al,. Radiation with concurrent late chemotherapy intensification ('chemoboost') for locally advanced head and neck cancer. Radiother Oncol 2000; 54: 123-7. (Pubitemid 30116762)
16. Rischin D, Peters LJ, O'Sullivan B, et al,. Tirapazamine, cisplatin and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): A phase III trial of the trans-tasman radiation oncology group. J Clin Oncol 2010; 28: 2989-95. Published online on May 17, 2010. doi:10.1200/JCO.2009.27.4449.
17. Posner MR, Hershock DM, Blajman CR, et al,. Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer. N Engl J Med 2007; 357: 1705-15. (Pubitemid 350005152)
18. Paulsen MG, Denham JW, Peters LJ, et al,. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous cell carcinoma of the head and neck: A trans-tasman radiation oncology group study. Radiother Oncol 2001; 60: 113-22. (Pubitemid 32601964)
19. Ang KK, Peters LJ, Weber RS, et al,. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 1990; 19: 1339-45.
20. Corry J, Peters LJ, Rischin D,. Optimizing the therapeutic ratio in head and neck cancer. Lancet Oncol 2010; 11: 287-91.
21. Porceddu S, Campbell B, Rischin D, et al,. Post-operative chemo-radiation for high-risk H&N SCC. Int J Radiat Oncol Biol Phys 2004; 60: 365-73.
22. Fung K, Lyden TH, Lee J, et al,. Voice and swallowing outcomes of an organ-preservation trial for advanced larynx cancer. Int J Radiat Oncol Biol Phys 2005; 63: 1395-99. (Pubitemid 41628034)
23. Hogikyan ND, Sethuraman G,. Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice 1999; 13: 557-69. (Pubitemid 30007814)
24. List MA, Ritter-Sterr C, Lansky SB,. A performance status scale for head and neck cancer patients. Cancer 1990; 66: 564-9. (Pubitemid 20233457)